Latest Influenza research Stories
New research from the Trudeau Institute may help to explain why live attenuated influenza vaccine (LAIV), commonly known as FluMist, elicits protection.
QUEBEC CITY, QC, Aug. 12, 2011 /PRNewswire/ - Medicago Inc.
GAITHERSBURG, Md., July 18, 2011 /PRNewswire/ -- MedImmune announced today that it has begun shipping FluMistÂ® (Influenza Vaccine Live, Intranasal) to influenza vaccine distributors who service health care providers throughout the United States.
SWIFTWATER, Pa., July 18, 2011 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that it began shipping its 2011-2012 FluzoneÂ® Influenza Virus Vaccine in the U.S.
The United Nationsâ€™ World Health Organization said on Thursday that worldwide production of seasonal flu vaccine is expected to double by 2015, with eleven new manufacturers ramping up in developing nations.
BLUE BELL, Pa., July 7, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
In a new research article, Harvard scientists outline a variety of factors that influence vaccine production and access to those vaccines.
The need to create a new flu vaccine annually could be eliminated with a universal influenza vaccine that targets a protein common to all strains of influenza A.
SAN FRANCISCO, June 7, 2011 /PRNewswire/ -- Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has begun dosing volunteers in a Phase I clinical trial.